Lung Transplant: Clinical Trials

2 trials for Lung Transplant, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Completed 1, Terminated 1

Follow Lung Transplant: new trials by email Literature Review of Lung Transplant trials Research Report on Lung Transplant

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Drug Interaction Study of Apixaban With Cyclosporine or Tacrolimus in Transplant Recipients
Apixaban - Pharmacokinetics, Kidney Transplant
Phase 4CompletedUniversity of Saskatchewan142019-06-262021-05-03
Lung Transplantation in Chronic HCV Infection With Post Transplant EPCLUSA Treatment
Epclusa - Hepatitis C, Chronic, Lung Transplant
Phase 4TerminatedDuke University12017-09-152019-09-11

Narrower conditions

Hepatitis C, Chronic (1)

Broader conditions

Blood-Borne Infections (1)  ·  Chronic Disease (1)  ·  Communicable Diseases (1)  ·  Digestive System Diseases (1)  ·  Disease Attributes (1)  ·  Flaviviridae Infections (1)  ·  Hepatitis (1)  ·  Hepatitis C (1)  ·  Hepatitis, Chronic (1)  ·  Hepatitis, Viral, Human (1)  ·  Infections (1)  ·  Liver Diseases (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  RNA Virus Infections (1)

Interventions

apixaban (1)  ·  sofosbuvir-velpatasvir drug combination (1)

Sponsors

Duke University (1)  ·  University of Saskatchewan (1)

Countries

Canada (1)  ·  United States (1)

Top investigators

Omar Mohamedaly, MD (1)

Results publications

PMID 35439353